Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD20m

    Last close

    USD3.57

    ▲ −2.08 (−36.81%)

    Faraday Future Intelligent Electric

    MCap

    USD10m

    Last close

    USD3.92

    ▲ −0.76 (−16.24%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sareum – executive interview

Sareum – executive interview

Sareum Holdings — 5 videos in collection

More on this equity

In this interview, Dr John Reader, co-founder and CSO of Sareum, discusses the publication of the Phase I data for lead candidate SDC-1801 in the British Journal of Clinical Pharmacology and explains why the results strengthen confidence in the programme as it advances towards Phase II. He highlights the drug’s favourable safety profile, once-daily dosing potential and evidence of selective TYK2/JAK1 inhibition, while outlining its potential advantages over competing dual TYK2/JAK1 inhibitor, brepocitinib. John also provides an update on Phase II preparations, including ongoing toxicology studies and formulation optimisation, before discussing the broad commercial opportunity for SDC-1801 across autoimmune diseases, Sareum’s partnering strategy and the key catalysts investors should watch over the next 12–18 months.

< Previous
Next >

You may also be interested in these:

Healthcare

Sareum Holdings – executive interview

Healthcare

Sareum Holdings – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.